$CFOO
China Foods Holdings Ltd.

2023 Q3 Form 10-Q Financial Statement

#000149315223027977 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $5.293K $6.840K $94.84K
YoY Change -1.89% -92.79% -64.47%
Cost Of Revenue $1.619K $1.538K $28.47K
YoY Change -92.8% -94.6% -51.97%
Gross Profit $3.674K $5.302K $66.36K
YoY Change -121.48% -92.01% -68.04%
Gross Profit Margin 69.41% 77.51% 69.98%
Selling, General & Admin $117.2K $139.3K $110.4K
YoY Change 18.05% 26.13% -36.32%
% of Gross Profit 3191.02% 2626.46% 166.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.830K $14.16K $16.57K
YoY Change -39.09% -14.56% -21.98%
% of Gross Profit 240.34% 267.07% 24.97%
Operating Expenses $117.2K $139.3K $110.4K
YoY Change 18.05% 26.13% -36.32%
Operating Profit -$113.6K -$134.0K -$44.04K
YoY Change -2.45% 204.14% -228.48%
Interest Expense $0.00 $0.00 $40.00
YoY Change -100.0% -100.0% -88.89%
% of Operating Profit
Other Income/Expense, Net $13.00 $241.00 $10.63K
YoY Change -99.93% -97.73% 2617.39%
Pretax Income -$113.6K -$133.7K -$33.42K
YoY Change 17.32% 300.12% -196.39%
Income Tax $4.305K
% Of Pretax Income
Net Earnings -$113.6K -$133.7K -$37.72K
YoY Change 20.56% 254.46% -208.81%
Net Earnings / Revenue -2145.31% -1954.85% -39.78%
Basic Earnings Per Share -$0.01 -$0.01 $0.00
Diluted Earnings Per Share -$0.01 -$0.01 -$1.863K
COMMON SHARES
Basic Shares Outstanding 20.25M shares 20.25M shares 20.25M shares
Diluted Shares Outstanding 20.25M shares 20.25M shares 20.25M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.0K $240.0K $477.2K
YoY Change -62.06% -49.71% -39.11%
Cash & Equivalents $157.4K $243.7K $477.2K
Short-Term Investments
Other Short-Term Assets $60.00K $60.00K $312.0K
YoY Change -77.82% -80.77% -42.44%
Inventory $119.2K $121.5K $300.5K
Prepaid Expenses
Receivables $5.107K $5.104K
Other Receivables $3.178K $2.766K $90.18K
Total Short-Term Assets $343.7K $431.3K $1.180M
YoY Change -66.81% -63.45% -31.78%
LONG-TERM ASSETS
Property, Plant & Equipment $17.66K $25.85K $92.87K
YoY Change -74.17% -72.17% -39.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $54.74K $28.61K $96.36K
YoY Change -23.48% -70.31% -38.43%
TOTAL ASSETS
Total Short-Term Assets $343.7K $431.3K $1.180M
Total Long-Term Assets $54.74K $28.61K $96.36K
Total Assets $398.4K $459.9K $1.276M
YoY Change -64.01% -63.97% -32.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.398K $1.398K
YoY Change
Accrued Expenses $220.0K $160.0K $165.2K
YoY Change 54.53% -3.17% -22.05%
Deferred Revenue $66.75K $69.97K $247.0K
YoY Change -71.29% -71.66%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $740.2K $688.1K $826.8K
YoY Change -6.58% -16.77% -3.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $183.1K
YoY Change -47.4%
Total Long-Term Liabilities $0.00 $0.00 $183.1K
YoY Change -100.0% -100.0% -47.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $740.2K $688.1K $826.8K
Total Long-Term Liabilities $0.00 $0.00 $183.1K
Total Liabilities $740.0K $690.0K $1.010M
YoY Change -21.97% -31.67% -16.39%
SHAREHOLDERS EQUITY
Retained Earnings -$1.627M -$1.514M -$1.033M
YoY Change 44.41% 46.59%
Common Stock $1.292M $1.292M $1.292M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$341.8K -$228.2K $266.5K
YoY Change
Total Liabilities & Shareholders Equity $398.4K $459.9K $1.276M
YoY Change -64.01% -63.97% -32.33%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$113.6K -$133.7K -$37.72K
YoY Change 20.56% 254.46% -208.81%
Depreciation, Depletion And Amortization $8.830K $14.16K $16.57K
YoY Change -39.09% -14.56% -21.98%
Cash From Operating Activities -$90.00K -$70.00K $13.75K
YoY Change -778.73% -609.09% -35.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K 20.00K -33.95K
YoY Change -86.34% -158.91% -214.81%
NET CHANGE
Cash From Operating Activities -90.00K -70.00K 13.75K
Cash From Investing Activities 0.000
Cash From Financing Activities -10.00K 20.00K -33.95K
Net Change In Cash -100.0K -50.00K -20.20K
YoY Change 170.27% 147.52% -139.8%
FREE CASH FLOW
Cash From Operating Activities -$90.00K -$70.00K $13.75K
Capital Expenditures $0.00
Free Cash Flow -$90.00K
YoY Change -778.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001310630
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32522
dei Entity Registrant Name
EntityRegistrantName
China Foods Holdings Ltd.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1735478
dei Entity Address Address Line1
EntityAddressAddressLine1
Room 2301A
dei Entity Address Address Line2
EntityAddressAddressLine2
China Resources Building
dei Entity Address Address Line3
EntityAddressAddressLine3
26 Harbour Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Wanchai
dei Entity Address Country
EntityAddressCountry
HK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0000
dei City Area Code
CityAreaCode
852
dei Local Phone Number
LocalPhoneNumber
3618-8608
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20252309 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243739 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
381709 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5104 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5120 usd
CY2023Q2 CFOO Deposits And Other Receivables
DepositsAndOtherReceivables
60955 usd
CY2022Q4 CFOO Deposits And Other Receivables
DepositsAndOtherReceivables
74813 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
121502 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
138582 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
431300 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
600224 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25847 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55495 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20341 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2762 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3148 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
28609 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
78984 usd
CY2023Q2 us-gaap Assets
Assets
459909 usd
CY2022Q4 us-gaap Assets
Assets
679208 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1398 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8013 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
161187 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
122660 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
69974 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73602 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21024 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15675 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15722 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
688143 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
661779 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20252309 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20252309 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20252309 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20252309 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2025 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2025 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1290355 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1290355 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6758 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2678 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1513856 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1272273 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-228234 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17429 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
459909 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
679208 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94835 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19045 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163634 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1538 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
28474 usd
us-gaap Cost Of Revenue
CostOfRevenue
11035 usd
us-gaap Cost Of Revenue
CostOfRevenue
47311 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
5302 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
66361 usd
us-gaap Gross Profit
GrossProfit
8010 usd
us-gaap Gross Profit
GrossProfit
116323 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
930 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2642 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3258 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2650 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138325 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107762 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
246917 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232691 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
139255 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
110404 usd
us-gaap Operating Expenses
OperatingExpenses
250175 usd
us-gaap Operating Expenses
OperatingExpenses
235341 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-133953 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44043 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-242165 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-119018 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
241 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
36 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
246 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
113 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10589 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
336 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10931 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
241 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10625 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
582 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11044 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-133712 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33418 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-241583 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107974 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4305 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6573 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-133712 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-37723 usd
us-gaap Net Income Loss
NetIncomeLoss
-241583 usd
us-gaap Net Income Loss
NetIncomeLoss
-114547 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3853 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19054 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4080 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19656 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-137565 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-56777 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-245663 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-134203 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20252309 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20252309 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20252309 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20252309 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20252309 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20252309 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20252309 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20252309 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17429 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-107871 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-227 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-90669 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-133712 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3853 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-228234 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
400701 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-76824 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-602 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
323275 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
323275 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-37723 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19054 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
266498 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
266498 usd
us-gaap Net Income Loss
NetIncomeLoss
-241583 usd
us-gaap Net Income Loss
NetIncomeLoss
-114547 usd
us-gaap Depreciation
Depreciation
28511 usd
us-gaap Depreciation
Depreciation
36191 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
243 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
259 usd
CFOO Non Cash Lease Expenses
NonCashLeaseExpenses
20274 usd
CFOO Non Cash Lease Expenses
NonCashLeaseExpenses
35814 usd
CFOO Adjustment Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-192555 usd
CFOO Adjustment Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-42283 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16 usd
CFOO Increase Decrease In Deposits And Other Receivables
IncreaseDecreaseInDepositsAndOtherReceivables
13858 usd
CFOO Increase Decrease In Deposits And Other Receivables
IncreaseDecreaseInDepositsAndOtherReceivables
15298 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17080 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27030 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
38527 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
7139 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6615 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-47 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8840 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3628 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-93832 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21168 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-49104 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-154532 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126912 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
19151 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-4796 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19151 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4796 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2589 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-512 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137970 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132220 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
381709 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
609434 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
243739 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
477214 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zRXvztXEFVd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zg2OgnJSyXNc">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue recognition at point in time and over time;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales returns at point in time and allowances;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inventory;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimated lives for tangible and intangible assets; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income tax valuation allowances</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Depreciation
Depreciation
14160 usd
us-gaap Depreciation
Depreciation
28511 usd
CY2022Q2 us-gaap Depreciation
Depreciation
16573 usd
us-gaap Depreciation
Depreciation
36191 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P10Y
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
120 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
243 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
127 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
259 usd
CFOO Sales Tax Percentage
SalesTaxPercentage
0.17 pure
CFOO Sales Tax Percentage
SalesTaxPercentage
0.17 pure
CFOO Product Sales Returns
ProductSalesReturns
0 usd
CFOO Product Sales Returns
ProductSalesReturns
4741 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94835 usd
us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than fifty percent (50%) likelihood of being realized upon ultimate settlement.
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
28474 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
66361 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2642 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107762 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
110404 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44043 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19045 usd
us-gaap Cost Of Revenue
CostOfRevenue
11035 usd
us-gaap Net Income Loss
NetIncomeLoss
-241583 usd
CY2023Q2 CFOO Working Capital
WorkingCapital
256843 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1538 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
5302 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
930 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138325 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
139255 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-133953 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94835 usd
us-gaap Gross Profit
GrossProfit
8010 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3258 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
246917 usd
us-gaap Operating Expenses
OperatingExpenses
250175 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-242165 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163634 usd
us-gaap Cost Of Revenue
CostOfRevenue
47311 usd
us-gaap Gross Profit
GrossProfit
116323 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2650 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232691 usd
us-gaap Operating Expenses
OperatingExpenses
235341 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-119018 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94835 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19045 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163634 usd
CY2023Q2 CFOO Rental Deposits
RentalDeposits
39947 usd
CY2022Q4 CFOO Rental Deposits
RentalDeposits
40115 usd
CY2023Q2 CFOO Purchase Deposits
PurchaseDeposits
18242 usd
CY2022Q4 CFOO Purchase Deposits
PurchaseDeposits
23835 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2766 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10863 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
60955 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
74813 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
121502 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
138582 usd
CFOO Allowance For Obsolete Inventories
AllowanceForObsoleteInventories
0 usd
CFOO Allowance For Obsolete Inventories
AllowanceForObsoleteInventories
0 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2 years, through May 16, 2023. Upon expiry, the Company renewed and leased an office premise under operating lease with a term of 1 year.
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20252309 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20252309 shares
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20341 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21024 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
21168 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
310297 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
322983 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
287176 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
258665 usd
CY2023Q2 CFOO Foreign Translation Difference Net
ForeignTranslationDifferenceNet
-2726 usd
CY2022Q4 CFOO Foreign Translation Difference Net
ForeignTranslationDifferenceNet
8823 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25847 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55495 usd
CY2023Q2 us-gaap Depreciation
Depreciation
14160 usd
us-gaap Depreciation
Depreciation
28511 usd
CY2022Q2 us-gaap Depreciation
Depreciation
16573 usd
us-gaap Depreciation
Depreciation
36191 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20252309 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20252309 shares
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6573 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6573 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
513290 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
459505 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
513290 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
459505 usd

Files In Submission

Name View Source Status
cfoo-20230630_pre.xml Edgar Link unprocessable
cfoo-20230630_cal.xml Edgar Link unprocessable
0001493152-23-027977-index-headers.html Edgar Link pending
0001493152-23-027977-index.html Edgar Link pending
0001493152-23-027977.txt Edgar Link pending
0001493152-23-027977-xbrl.zip Edgar Link pending
cfoo-20230630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cfoo-20230630_lab.xml Edgar Link unprocessable
cfoo-20230630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending